Drug intelligence / Profile preview

BPI-9016M

Development stage
Phase 1
Lead developer
Betta Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Administration
Oral
01

Overview

BPI-9016M is a novel, orally active small molecule tyrosine kinase inhibitor that selectively targets both c-MET and AXL receptor tyrosine kinases. By binding to these targets, BPI-9016M disrupts c-MET and AXL-mediated signaling pathways, leading to inhibition of tumor cell growth, migration, and invasion in cancers with overexpression or dysregulation of these kinases. It is being developed by Betta Pharmaceuticals for advanced non-small cell lung cancer (NSCLC), particularly in patients with c-MET overexpression or MET exon 14 skipping mutations.

02

Targets

AXL (AXL receptor tyrosine kinase)MET (Mesenchymal-epithelial transition factor receptor)

Beyond the preview

Go deeper on BPI-9016M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BPI-9016M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call